Charles Schwab’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $418K | Hold |
|
|||||
|
2022
Q4 | $251K | Sell |
|
|||||
|
2022
Q3 | $569K | Sell |
|
|||||
|
2022
Q2 | $736K | Sell |
|
|||||
|
2022
Q1 | $1.88M | Buy |
|
|||||
|
2021
Q4 | $1.2M | Buy |
|
|||||
|
2021
Q3 | $1.07M | Sell |
|
|||||
|
2021
Q2 | $1.76M | Buy |
|
|||||
|
2021
Q1 | $2.06M | Sell |
|
|||||
|
2020
Q4 | $1.78M | Sell |
|
|||||
|
2020
Q3 | $2.52M | Buy |
|
|||||
|
2020
Q2 | $1.96M | Buy |
|
|||||
|
2020
Q1 | $1.11M | Buy |
|
|||||
|
2019
Q4 | $1.72M | Buy |
|
|||||
|
2019
Q3 | $336K | Buy |
|
|||||
|
2019
Q2 | $475K | Buy |
|
|||||
|
2019
Q1 | $588K | Buy |
|
|||||
|
2018
Q4 | $285K | Buy |
|
|||||
|
2018
Q3 | $494K | Buy |
|
|||||
|
2018
Q2 | $368K | Buy |
|
|||||
|
2018
Q1 | $891K | Sell |
|
|||||
|
2017
Q4 | $543K | Buy |
|
|||||
|
2017
Q3 | $646K | Buy |
|
|||||
|
2017
Q2 | $340K | Buy |
|
|||||
|
2017
Q1 | $273K | Buy |
|